The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

The FDA has approved a polypill as an initial treatment for hypertension in adults for the first time. Here’s what to know: 1. Widaplik — manufactured by George Medicines — is a polypill that contains ...

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for ...

The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults.

The analyst behind the change is now bullish on Teva's future. The person behind the modification was JPMorgan Chase analyst Chris Schott, who pushed up his Teva stock recommendation one notch ...

Teva's Q4 earnings reveal significant headwinds, including declining U.S. generics revenue and rising costs in the API business, impacting overall profitability. Branded drugs like Austedo and ...

SOPA Images / Contributor / Getty Images Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 treatment for eye disorders.

"2024 marked a transformative year for Teva, resulting in a second consecutive year of growth, driven by our generic products and key innovative products," said Teva CEO. Teva Pharmaceutical ...

In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands among Wednesday’s worst-performing stocks. The stock market declined on Wednesday ...

Despite finishing strong across both its innovative and generic businesses in 2024, Teva’s cautious approach to the new year appears to have investors spooked. Teva on Wednesday reported that ...

The Labor Ministry opened an investigation into corruption against Teva Pharmaceutical Industries Ltd. following a complaint by a company employee filed in 2024. The employee who submitted the ...